iBio
IBIO
28 hedge funds and large institutions have $3.24M invested in iBio in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 5 closing their positions.
886% more capital invested
Capital invested by funds: $329K → $3.24M (+$2.91M)
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
75% more funds holding
Funds holding: 16 → 28 (+12)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$647K |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$245K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$224K |
| 4 |
Jane Street
New York
|
+$77K |
| 5 |
Goldman Sachs
New York
|
+$74.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$75.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$9K |
| 4 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$7.7K |
| 5 |
Barclays
London,
United Kingdom
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$29K | -236 | Closed |
|
|
27
UBS Group
Zurich,
Switzerland
| – | -$75.4K | -196 | -99% |
|
|
28
Creative Planning
Overland Park,
Kansas
| – | -$9K | -69 | Closed |
|
|
29
Barclays
London,
United Kingdom
| – | -$7K | -60 | Closed |
|
30
HighTower Advisors
Chicago,
Illinois
| – | -$2K | -20 | Closed |
|
|
PFGIA
31
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| – | -$7.7K | -20 | Closed |
|
|
OPS
32
Orion Portfolio Solutions
Omaha,
Nebraska
| – | +$385 | +1 | New |
|
|
IA
33
IFP Advisors
Tampa,
Florida
| – | +$770 | +2 | New |
|
IBIO Hedge Fund Activity: Q1 2020 in Review
28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2020, worth a combined $3.24M — up 886% from $329K a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new IBIO positions and 5 closed out — a net gain of 14 holders — while 8 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $647K. The largest seller was UBS Group, cutting an estimated $75.4K.
- 28 institutional investors held iBio (IBIO) as of Q1 2020, up from 16 in Q4 2019.
- Funds reported $3.24M of iBio stock for Q1 2020, up 886% quarter-over-quarter.
- 19 funds opened new iBio positions in Q1 2020 and 5 closed out, a net change of +14 holders.
- The largest iBio buyer in Q1 2020 was Vanguard Group, an estimated $647K added.
- The largest iBio seller in Q1 2020 was UBS Group, an estimated $75.4K sold.
Based on aggregated 13F filings for Q1 2020.